The light at the end of the tunnel: is COPD prevalence changing?

Celli B.R.

Source: Eur Respir J 2010; 36: 718-719
Journal Issue: October
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Celli B.R.. The light at the end of the tunnel: is COPD prevalence changing?. Eur Respir J 2010; 36: 718-719

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improving outcomes in patients with non-tuberculous mycobacterial disease: is there light at the end of the tunnel?
Source: Eur Respir J, 54 (1) 1901149; 10.1183/13993003.01149-2019
Year: 2019



Characterization of asthma and COPD overlap: a single center study
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


Identifying the at risk smokers: who goes on to get COPD?
Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019
Year: 2019



COPD: time to improve its taxonomy?
Source: ERJ Open Res, 4 (1) 00132-2017; 10.1183/23120541.00132-2017
Year: 2018



The most beautiful COPD chart in the world: all together to end COPD!
Source: Eur Respir J, 54 (6) 1902047; 10.1183/13993003.02047-2019
Year: 2019



Finding the true prevalence of obstructive lung disease: two steps forward and one step back
Source: Eur Respir J, 55 (6) 2001514; 10.1183/13993003.01514-2020
Year: 2020



LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Importance of inhaler device use status in the control of asthma and COPD: a real life study.
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006


Asthma, COPD and their overlap: coexistence or something more?
Source: Eur Respir J, 58 (5) 2101329; 10.1183/13993003.01329-2021
Year: 2021



Late diagnosis of CF: what should respiratory physicians be looking for?
Source: International Congress 2014 – ERS/European Cystic Fibrosis Society: “The provision of care for adults with cystic fibrosis (CF) in Europe"
Year: 2014



COPD prevalence in a random population survey: a matter of definition
Source: Eur Respir J 2007; 30: 232-239
Year: 2007



Patients' perception of peakflowmeters use in Ukraine: does it pose an issue for asthma control?
Source: Eur Respir J 2002; 20: Suppl. 38, 540s
Year: 2002

Predicting poor prognosis in COPD patients: looking for a lamp lit in the darkness of the night
Source: Eur Respir J 2014; 43: 1560-1562
Year: 2014


“When you’re at work you’ve got a goal [..] but that’s all finished for me now”; exploring goal perception amongst people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017

Understanding the impact of physical activity in COPD outcomes: moving forward
Source: Eur Respir J 2014; 44: 1107-1109
Year: 2014


Debating the definition of airflow obstruction: time to move on?
Source: Eur Respir J 2009; 34: 527
Year: 2009


Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?
Source: Eur Respir J 2011; 37: 489-491
Year: 2011